Cargando…
Resolvin E1-ChemR23 Axis Regulates the Hepatic Metabolic and Inflammatory Transcriptional Landscape in Obesity at the Whole Genome and Exon Level
Resolvin E1 (RvE1) is an immunoresolvent that is synthesized from eicosapentaenoic acid and can bind the receptor ERV1/ChemR23. We previously showed activation of the RvE1-ChemR23 axis improves hyperglycemia and hyperinsulinemia of obese mice; however, it remains unclear how RvE1 controls glucose ho...
Autores principales: | Al-Shaer, Abrar E., Pal, Anandita, Shaikh, Saame Raza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740313/ https://www.ncbi.nlm.nih.gov/pubmed/35004828 http://dx.doi.org/10.3389/fnut.2021.799492 |
Ejemplares similares
-
Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease Through the Resolvin E1 and ChemR23 Axis
por: Artiach, Gonzalo, et al.
Publicado: (2020) -
Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157)
por: Berg, Vivian, et al.
Publicado: (2010) -
Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction
por: Xie, Yingying, et al.
Publicado: (2022) -
Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy
por: Shang, Jin, et al.
Publicado: (2019) -
Chemerin/ChemR23 pathway: a system beyond chemokines
por: Iannone, Florenzo, et al.
Publicado: (2011)